Substance / Medication

Sulfapyridine

Overview

Active Ingredient
sulfapyridine
RxNorm CUI
10188

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

3 trials linked to this intervention

3
Total Trials
0
Recruiting
1
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Efficacy of iguratimodsalazosulfapyridine as the first-line csDMARD for rheumatoid arthritis.
Nozaki Yuji, Inoue Asuka, Kinoshita Koji et al. · Mod Rheumatol · 2020
PMID: 30676812Observational
On the action of 5-amino-salicylic acid and sulfapyridine on M. avium including subspecies paratuberculosis.
Greenstein Robert J, Su Liya, Shahidi Azra et al. · PLoS One · 2007
PMID: 17565369ObservationalFull text (PMC)
[Effectiveness of methotrexate for the escape by salazosulfapyridine].
Kawasaki Yoichi, Moriyama Masahiro, Shibata Kazuhiko et al. · Yakugaku Zasshi · 2005
PMID: 15997214Observational
Autoimmune Pulmonary Alveolar Proteinosis Triggered by Salazosulfapyridine in a Patient With Rheumatoid Arthritis: A Case Report.
Ikeuchi Tomoyuki, Yamamoto Mitsuhiro, Touge Hirokazu et al. · Cureus · 2025
PMID: 41573481Case ReportFull text (PMC)
Successful treatment of erythema nodosum with salazosulfapyridine in a 9-year-old patient with chronic non-bacterial osteomyelitis.
Shimomura Masaki, Okura Yuka, Takahashi Yutaka et al. · Mod Rheumatol Case Rep · 2024
PMID: 38597876Case Report

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Sulfapyridine (substance)
SNOMED CT
27082000
UMLS CUI
C0038710
RxNorm CUI
10188

Clinical Data

This intervention maps to 4 entities in the Healos knowledge graph.

4
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
3
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.